Industry Roundup: Church & Dwight Earnings, Nicoderm CQ Label Warning
This article was originally published in The Tan Sheet
Executive Summary
AstaZine carries 239 structure/function claims; FDA warns on misbranded supplements, cosmetics; Georgia joins NPLEx; and more news in brief.
You may also be interested in...
Drug-Spiked Coffee Recalled With Link To Death Suspected
Malaysian firm marketing spiked product states on its e-commerce site, "Warning … please make sure you are healthy enough to accept these wonderful new changes."
Weight Loss Claims Land Firms On FTC Radar In First ‘Negative Option’ Case
FTC says Health Formulas LLC of Las Vegas, and its associated firms in Nevada and California, make unsubstantiated claims for green coffee bean extract and other supplement products. A judge issued a temporary injunction against the firms from using “free” trial offers and deceptive health claims.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.